Under construction – not a live service
Sign in

Fatty liver disease (MASLD/MASH) trials in United States

101 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

  • No phaseTaking people
    Endoscopic Ultrasound Shear Wave Elastography Study
    Where
    Boston, Danville, Newport Beach
    Age
    18 years and over
    People
    300
    Run by
    Olympus Corporation of the Americas
  • No phaseNot yet taking people in United States
    Isocaloric Navy-Bean Substitution in Adults With MASLD
    Where
    New York
    Age
    18 years to 75 years
    People
    40
    Run by
    Icahn School of Medicine at Mount Sinai
  • No phaseTaking people
    NAFLD Clinical Care Pathway
    Where
    Houston
    Age
    18 years to 80 years
    People
    32
    Run by
    VA Office of Research and Development
  • Phase 2Taking people
    A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
    Where
    Akron, Apple Valley, Austin, Bellaire, Bradenton, Brownsville, Chandler, Columbia, Cordova, Corpus Christi, Covington, Dayton, Decatur, Edinburg, Farmers Branch, Fayetteville, Forney, Fort Worth, Fountain Valley, Garland, Georgetown, Glenview, Greenbelt, Gurnee, Houma, Houston, Jupiter, La Jolla, Lancaster, Las Vegas, Little Rock, Long Beach, Marietta, Marlton, Marrero, Metairie, Miami, Miami Lakes, Monroe, Ocala, Orange, Pasadena, Peoria, Port Orange, Richmond, San Antonio, Shreveport, South Bend, Sparta, Springboro, St Louis, Sugar Land, Tucson, Victorville, Viera, Waco, Webster, Westlake, West Monroe, West Palm Beach, Wichita Falls
    Age
    18 years to 75 years
    People
    160
    Run by
    Eccogene
  • Phase 2Taking people
    Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
    Where
    Arlington, Austin, Dallas, Danville, Doral, Fort Myers, Georgetown, Houston, Indianapolis, Marrero, Metairie, Miami, Nashville, Pasadena, Rialto, San Antonio, Sugar Land, Topeka, Tucson
    Age
    18 years to 75 years
    People
    360 worldwide
    Run by
    Regeneron Pharmaceuticals
    See details and how to joinNCT07631637 · EU 2026-525916-33-00
  • Phase 3Taking people
    A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
    Where
    Amarillo, Atlanta, Aurora, Austin, Baltimore, Bastrop, Bellaire, Birmingham, Bradenton, Brandon, Brownsville, Buffalo, Chandler, Chapel Hill, Charleston, Charlotte, Chattanooga, Chicago, Chula Vista, Clarksville, Colorado Springs, Columbia, Columbus, Conway, Coronado, Corpus Christi, Covington, Dallas, Dayton, Denison, Doral, Dothan, Durham, Edinburg, Englewood, Escondido, Falls Church, Fayetteville, Flagstaff, Florham Park, Flowood, Folsom, Forney, Fort Myers, Fort Worth, Gainesville, Glen Burnie, Greenbelt, Hammond, Hermitage, Hershey, Hialeah Gardens, Houma, Houston, Indianapolis, Inglewood, Inverness, Jackson, Jacksonville, Jonesboro, Kansas City, Lady Lake, Lakewood Rch, La Mesa, Lancaster, Largo, Las Vegas, Lehigh Acres, Lewisville, Little Rock, Long Beach, Los Angeles, Louisville, Madison, Maitland, Manhasset, Margate, Marietta, Marrero, McAllen, Metairie, Miami, Miami Gardens, Miami Lakes, Morehead City, Naples, Nashville, New Bedford, New Bern, New Haven, New Orleans, Newport Beach, Newport News, New Port Richey, New York, Norfolk, North Little Rock, Novi, Ocala, Ogden, Orange, Orlando, Palm Springs, Pasadena, Pembroke Pines, Peoria, Philadelphia, Pittsburgh, Port Orange, Raleigh, Redwood City, Reno, Richmond, Ridgewood, Riverview, Roanoke, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, Sandy City, San Francisco, San Marcos, Santa Fe, Santa Maria, Sarasota, Seattle, Shreveport, Somers Point, South Bend, Southfield, South Ogden, Sparta, Spokane, Springboro, Statesville, St Louis, Suffolk, Summerville, Temple Terrace, Topeka, Tucson, Venice, Viera, Waco, Washington D.C., Webster, West Des Moines, Westlake, West Monroe, Weston, West Palm Beach, Wichita, Wichita Falls, Winter Park, Wyoming, Ypsilanti, Zephyrhills
    Age
    18 years to 80 years
    People
    1,650 worldwide
    Run by
    Akero Therapeutics, Inc
  • Phase 2Taking people
    A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
    Where
    Austin, Baltimore, Chandler, Dallas, Fayetteville, Fresno, Georgetown, Houston, Kansas City, Lancaster, Marietta, Mesa, Miami, New York, Pasadena, Pearland, Rialto, Richmond, San Antonio, Santa Maria, Tucson, Viera, Waco, Wilson
    Age
    18 years to 75 years
    People
    42
    Run by
    GlaxoSmithKline
  • Phase 1Taking people
    A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
    Where
    Houston, Miami Lakes, Rialto, San Antonio, Tampa
    Age
    18 years to 70 years
    People
    32
    Run by
    GlaxoSmithKline
  • Phase 3Taking people
    A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
    Where
    Arlington, Austin, Bellaire, Cape Coral, Dallas, Folsom, Fort Myers, Hialeah, Homestead, Humble, Kissimmee, Lakeland, Little Rock, Manassas, Miami, Morehead City, New York, Ocala, San Antonio, Santa Maria, St Louis, University Park, Waco, West Jordan, Westlake
    Age
    18 years to 75 years
    People
    1,740 worldwide
    Run by
    GlaxoSmithKline
  • Phase 3Taking people
    A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
    Where
    Arcadia, Arlington, Arroyo Grande, Austin, Bellaire, Cape Coral, Dallas, East Syracuse, Folsom, Fort Myers, Hialeah, Homestead, Houston, Humble, Kissimmee, Lakeland, Little Rock, Manassas, Miami, Morehead City, New York, Ocala, San Antonio, Springboro, St Louis, University Park, Van Nuys, Waco, West Jordan, Westlake
    Age
    18 years to 75 years
    People
    380 worldwide
    Run by
    GlaxoSmithKline
  • Phase 3Taking people
    Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Where
    Georgetown, Marrero, Metairie, Miami
    Age
    18 years to 75 years
    People
    1,500
    Run by
    Regeneron Pharmaceuticals
    See details and how to joinNCT07854782 · EU 2026-526723-22-00
  • Phase 3Not yet taking people in United States
    ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
    Where
    Albuquerque, Boston, Bristol, Dallas, Durham, Kansas City, Los Angeles, Oxnard, Pasadena, Peoria, Statesville, Summerville, Topeka, University Park, West Hills
    Age
    18 years and over
    People
    600 worldwide
    Run by
    Boehringer Ingelheim
    See details and how to joinNCT07850063 · EU 2026-527091-88-00
  • Phase 3Taking people
    LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
    Where
    Altamonte Springs, Arlington, Austin, Baltimore, Bastrop, Bellaire, Birmingham, Boston, Bradenton, Brandon, Bristol, Brooklyn, Brooksville, Brownsville, Canoga Park, Carrollton, Charleston, Chattanooga, Chesterfield, Chula Vista, Clarksville, Clearwater, Clermont, Clinton Township, Clive, Colorado Springs, Columbia, Columbus, Coral Gables, Coronado, Corpus Christi, Cutler Bay, Dallas, Denison, DeSoto, Durham, Edinburg, Englewood, Fayetteville, Flourtown, Flowood, Forney, Fort Myers, Fountain Valley, Fresno, Gainesville, Gardena, Garden City, Garland, Georgetown, Greenville, Hammond, Hershey, Hialeah, Hialeah Gardens, Homestead, Houston, Huntington Park, Inglewood, Kansas City, Lady Lake, Lakewood Rch, La Mesa, Lancaster, Las Vegas, Laurelton, Lewisville, Long Beach, Los Angeles, Macon, Maitland, Mansfield, Marrero, McAllen, Mentor, Miami, Miami Lakes, Minneapolis, Montclair, Naples, Nashville, New Bern, New Haven, Newport News, New York, Omaha, Orange, Orlando, Oxnard, Palmetto Bay, Pasadena, Pembroke Pines, Peoria, Plano, Port Orange, Poway, Raleigh, Rialto, Richmond, Riverdale, Riverview, Rochester, San Antonio, San Bernardino, San Diego, Santa Ana, Scottsdale, Seattle, Shreveport, South Bend, Spokane, Springboro, State College, St. Petersburg, Summerville, Tampa, The Villages, Topeka, Tucson, Tulsa, University Park, Van Nuys, Victorville, Waco, Warren Township, West Des Moines, Westlake, Wichita Falls, Winter Park, Wyoming, Wyomissing, Zephyrhills
    Age
    18 years and over
    People
    1,800 worldwide
    Run by
    Boehringer Ingelheim
    See details and how to joinNCT06632444 · EU 2024-513739-25-00
  • Phase 3Taking people
    LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
    Where
    Arlington, Atlanta, Austin, Bastrop, Bellaire, Bradenton, Brandon, Bristol, Brooklyn, Brooksville, Brownsville, Canoga Park, Chattanooga, Chula Vista, Clarksville, Clinton Township, Colorado Springs, Columbia, Columbus, Coral Gables, Coronado, Cutler Bay, Dallas, Denison, Englewood, Fayetteville, Flourtown, Fort Myers, Fountain Valley, Garden City, Garland, Georgetown, Greenville, Hammond, Hershey, Hialeah, Hialeah Gardens, Homestead, Houston, Huntington Park, Inglewood, Kansas City, Lady Lake, La Mesa, Lancaster, Las Vegas, Laurelton, Lewisville, Macon, Mansfield, Marrero, McAllen, Mentor, Miami, Miami Lakes, Minneapolis, Montclair, Nashville, New Port Richey, New York, Omaha, Orange, Orlando, Oxnard, Palmetto Bay, Pembroke Pines, Peoria, Poway, Raleigh, Rialto, Richmond, Riverdale, Riverview, Rochester, San Antonio, San Bernardino, San Diego, Scottsdale, Seattle, Shreveport, South Bend, Spokane, Springboro, St. Petersburg, Summerville, Tampa, The Villages, Tucson, Tulsa, University Park, Waco, Warren Township, West Des Moines, Westlake, Wichita Falls, Winter Park, Wyoming, Wyomissing, Zephyrhills
    Age
    18 years and over
    People
    1,590 worldwide
    Run by
    Boehringer Ingelheim
    See details and how to joinNCT06632457 · EU 2024-513741-36-00
  • Phase 2Taking people
    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
    Where
    Bethesda
    Age
    18 years to 100 years
    People
    104
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • No phaseTaking people
    Evaluation of Non-Invasive Tests for Metabolic Liver Disease
    Where
    Bellaire, Columbus, Miami, San Antonio
    Age
    18 years to 75 years
    People
    400
    Run by
    Foundation for the National Institutes of Health
  • Phase 3Taking people
    A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
    Where
    Akron, Albany, Albuquerque, Amarillo, Athens, Austin, Baltimore, Bellaire, Bellevue, Birmingham, Brandon, Brownsville, Burlington, Canoga Park, Carmel, Chandler, Charleston, Charlotte, Chattanooga, Chesterfield, Chicago, Clermont, Cleveland, Colorado Springs, Columbia, Conway, Cordova, Coronado, Corpus Christi, Covington, Dalton, Dayton, Denton, DeSoto, Durham, East Greenwich, Edinburg, Escondido, Farmers Branch, Fayetteville, Flagstaff, Florham Park, Flowood, Fort Myers, Fort Sam Houston, Fort Worth, Fountain Valley, Freehold, Fresno, Gardena, Garland, Georgetown, Glen Burnie, Glendale, Greenbelt, Hammond, Hermitage, Hialeah Gardens, Homestead, Houma, Houston, Huntington Park, Inglewood, Iowa City, Jacksonville, Jupiter, Katy, Lady Lake, La Jolla, Lake Charles, Lakewood Rch, Lancaster, Las Vegas, Lehigh Acres, Lewisville, Liberty Township, Lima, Little Rock, Littleton, Long Beach, Los Angeles, Louisville, Lubbock, Maitland, Maplewood, Marietta, Marrero, Miami, Montclair, Morehead City, Nashville, New Albany, New Orleans, New Port Richey, New York, North Little Rock, Ocala, Ocoee, Ogden, Orange, Panorama City, Pasadena, Poway, Raleigh, Rialto, Richmond, Roanoke, Rochester, San Antonio, Santa Ana, Sarasota, Seattle, South Bend, Southlake, Springboro, Stafford, Stanford, St Louis, Sugar Land, Sun City, Tacoma, Tomball, Topeka, Tucson, Tyler, Victorville, Waco, Warren Township, Westlake, West Monroe, Wilmington, Winston-Salem, Winter Park, Wyoming, Ypsilanti
    Age
    18 years to 80 years
    People
    1,350 worldwide
    Run by
    Hoffmann-La Roche
    See details and how to joinNCT06318169 · EU 2023-509912-27-00
  • Phase 3Taking people
    A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
    Where
    Akron, Albany, Albuquerque, Amarillo, Ann Arbor, Asheville, Athens, Atlanta, Austin, Baltimore, Bellevue, Birmingham, Brownsville, Burlington, Camarillo, Canoga Park, Chandler, Charleston, Charlotte, Chicago, Cincinnati, Clermont, Cleveland, Clinton Township, Columbia, Columbus, Cordova, Coronado, Dayton, DeSoto, Detroit, Durham, East Greenwich, Edinburg, Farmers Branch, Fayetteville, Flagstaff, Florham Park, Flowood, Fort Myers, Fort Worth, Fountain Valley, Framingham, Fresno, Gainesville, Georgetown, Glen Burnie, Glenview, Greenbelt, Greenville, Hammond, Harlingen, Hermitage, Hialeah Gardens, Homestead, Homewood, Houston, Huntington Park, Iowa City, Jacksonville, Kansas City, Lady Lake, Lafayette, La Jolla, Lake Charles, Lakewood Rch, Las Vegas, Lehigh Acres, Lewisville, Liberty Township, Little Rock, Littleton, Los Angeles, Louisville, Lubbock, Maitland, Mansfield, Marietta, Miami, Minneapolis, Nashville, New Albany, New Port Richey, New York, North Little Rock, Ocala, Ocoee, Orlando, Pasadena, Pearland, Peoria, Philadelphia, Phoenix, Pittsburgh, Poway, Rapid City, Redwood City, Rialto, Richmond, Rochester, Sacramento, San Antonio, Sandy City, San Marcos, Santa Ana, Seattle, Somers Point, South Bend, Southlake, St Louis, Sun City, Tacoma, Topeka, Tucson, Tupelo, Tyler, University Park, Viera, Waco, West Jordan, Westlake, West Monroe, Winston-Salem, Winter Park, Wyoming, Ypsilanti
    Age
    18 years to 75 years
    People
    1,800 worldwide
    Run by
    Hoffmann-La Roche
    See details and how to joinNCT06419374 · EU 2023-510395-31-00
  • Phase 4Taking people
    Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
    Where
    Cleveland
    Age
    18 years to 70 years
    People
    70
    Run by
    The Cleveland Clinic
  • No phaseEnrolling by invitation
    Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
    Where
    Columbia
    Age
    18 years to 80 years
    People
    750
    Run by
    University of Missouri-Columbia
  • Phase 1Taking people
    Resmetirom in Patients With MASH and HFpEF
    Where
    Fort Myers, Oxnard, Peoria, Riverview, University Park
    Age
    18 years and over
    People
    90
    Run by
    Madrigal Pharmaceuticals, Inc.
  • Phase 4Taking people
    Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis
    Where
    Arlington, Chandler, Chattanooga, Cincinnati, Coronado, Corpus Christi, Dallas, Lake Charles, Lakewood Rch, McAllen, Miami, Morehead City, North Little Rock, Rialto, San Antonio
    Age
    18 years and over
    People
    150
    Run by
    Madrigal Pharmaceuticals, Inc.
  • Phase 2Taking people
    A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
    Where
    Arlington, Baltimore, Carrollton, Chandler, Charleston, Colorado Springs, Columbus, Coronado, Dallas, Fort Worth, Houston, Iowa City, Kansas City, La Mesa, Los Angeles, Miami, Miami Lakes, Montclair, Morehead City, Nashville, New York, Rochester, San Antonio, University Park
    Age
    18 years to 75 years
    People
    30 worldwide
    Run by
    Boehringer Ingelheim
  • Phase 3Taking people
    A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
    Where
    Akron, Amarillo, Arlington, Atlanta, Aurora, Austin, Baltimore, Bastrop, Bellaire, Bethesda, Birmingham, Bradenton, Brandon, Brownsville, Buffalo, Chandler, Chapel Hill, Charleston, Charlotte, Chicago, Clarksville, Clinton Township, Colorado Springs, Columbia, Conway, Coronado, Corpus Christi, Covington, Cutler Bay, Dallas, Daytona Beach, Denison, Doral, Dothan, Durham, Edinburg, Englewood, Escondido, Fayetteville, Flagstaff, Flowood, Folsom, Fort Myers, Fort Sam Houston, Fort Worth, Fountain Valley, Gainesville, Garland, Hammond, Henderson, Hermitage, Hershey, Hialeah Gardens, Houma, Houston, Indianapolis, Inverness, Jackson, Jonesboro, Kansas City, Kingwood, Lady Lake, Lafayette, Lakewood Rch, Lancaster, Largo, Las Vegas, Lehigh Acres, Little Rock, Long Beach, Los Angeles, Louisville, Madison, Manhasset, Margate, Marietta, Marrero, Metairie, Miami, Miami Gardens, Morehead City, Naples, Nashville, New Haven, Newport Beach, New Port Richey, New York, Norfolk, North Little Rock, Novi, Ocala, Oklahoma City, Orange, Orlando, Pasadena, Pembroke Pines, Peoria, Pharr, Philadelphia, Pittsburgh, Raleigh, Redwood City, Richmond, Riverview, Roanoke, Rochester, Sacramento, San Antonio, San Francisco, San Jose, Sarasota, Scottsdale, Seattle, Shreveport, Snellville, Somers Point, South Bend, South Dartmouth, Southfield, Sparta, Springboro, Statesville, St Louis, Sugar Land, Summerville, Tarzana, Temple Terrace, Topeka, Tucson, Vancouver, Venice, Viera, Waco, Washington D.C., Webster, West Des Moines, Westlake, West Monroe, Weston, Wichita Falls, Zephyrhills
    Age
    18 years to 80 years
    People
    2,150 worldwide
    Run by
    Akero Therapeutics, Inc
  • No phaseNot yet taking people in United States
    AGED Diagnostics Clinical Validation Study
    Where
    Bethesda
    Age
    18 years to 75 years
    People
    500
    Run by
    Active Genomes Expressed Diagnostics, Corp